Identification of Isocitrate Dehydrogenase 2 (IDH2) Mutation in Carotid Body Paraganglioma
Authors:
Open Access
- 20 September 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 12
Abstract
Carotid body paragangliomas (PGLs) are rare neuroendocrine tumors that develop within the adventitia of the medial aspect of the carotid bifurcation. Carotid body PGLs comprise about 65% of head and neck paragangliomas, however, their genetic background remains elusive. In the present study, we report one case of carotid body PGL with a somatic mutation in the gene encoding isocitrate dehydrogenase 2 (IDH2). The missense mutation in IDH2 resulted in R172G amino acid substitution, which exhibits neomorphic activity and production of D-2-hydroxyglutarate.Keywords
This publication has 26 references indexed in Scilit:
- Sensitive Determination of Onco-metabolites of D- and L-2-hydroxyglutarate Enantiomers by Chiral Derivatization Combined with Liquid Chromatography/Mass Spectrometry AnalysisScientific Reports, 2015
- Metabolic consequences of oncogenic IDH mutationsPharmacology & Therapeutics, 2015
- Isocitrate dehydrogenase mutations in gliomasNeuro-Oncology, 2015
- Mutant glucocerebrosidase in Gaucher disease recruits Hsp27 to the Hsp90 chaperone complex for proteasomal degradationProceedings of the National Academy of Sciences, 2015
- Oncogenic Isocitrate Dehydrogenase Mutations: Mechanisms, Models, and Clinical OpportunitiesCancer Discovery, 2013
- Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomasBlood, 2013
- Genetics and molecular pathogenesis of pheochromocytoma and paragangliomaClinical Endocrinology, 2013
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent DioxygenasesCancer Cell, 2011
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarateNature, 2009
- Assignment of the Human Mitochondrial NAD+-Specific Isocitrate Dehydrogenase α Subunit (IDH3A) Gene to 15q25.1 → q25.2 byin SituHybridizationGenomics, 1996